Skip to content
2000
Volume 25, Issue 3
  • ISSN: 1566-5240
  • E-ISSN: 1875-5666

Abstract

Background

Chronic hyperglycemia in diabetes induces oxidative stress, leading to damage to the vascular system. In this study, we aimed to evaluate the effects and mechanisms of AS-IV-Exos in alleviating endothelial oxidative stress and dysfunction caused by high glucose (HG).

Methods

Histopathological changes were observed using HE staining, and CD31 expression was assessed through immunohistochemistry (IHC). Cell proliferation was evaluated through CCK8 and EDU assays. The levels of ROS, SOD, and GSH-Px in the skin tissues of each group were measured using ELISA. Cell adhesion, migration, and tube formation abilities were assessed using adhesion, Transwell, and tube formation experiments. ROS levels in HUVEC cells were measured using flow cytometry. The levels of miR-210 and Nox2 were determined through quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The expression of Nox2, SOD, GSH-Px, CD63, and CD81 was confirmed using WB.

Results

The level of miR-210 was reduced in diabetes-induced skin damage, while the levels of Nox2 and ROS increased. Treatment with AS-IV increased the level of miR-210 in EPC-Exos. Compared to Exos, AS-IV-Exos significantly reduced the proliferation rate, adhesion number, migration speed, and tube-forming ability of HG-damaged HUVEC cells. AS-IV-Exos also significantly decreased the levels of SOD and GSH-Px in HG-treated HUVEC cells and reduced the levels of Nox2 and GSH-Px. However, ROS levels and Nox2 could reverse this effect.

Conclusion

AS-IV-Exos effectively alleviated endothelial oxidative stress and dysfunction induced by HG through the miR-210/Nox2/ROS pathway.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmm/10.2174/0115665240262982240109104620
2025-03-01
2025-08-18

  • From This Site

    /content/journals/cmm/10.2174/0115665240262982240109104620
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. BaiS. YinQ. DongT. Endothelial progenitor cell-derived exosomes ameliorate endothelial dysfunction in a mouse model of diabetes.Biomed. Pharmacother.202013111075610.1016/j.biopha.2020.110756 33152921
     [Google Scholar]
  2. LiX. ChenC. WeiL. Exosomes derived from endothelial progenitor cells attenuate vascular repair and accelerate reendothelialization by enhancing endothelial function.Cytotherapy201618225326210.1016/j.jcyt.2015.11.009 26794715
     [Google Scholar]
  3. MaX. WangJ. LiJ. Loading MiR-210 in Endothelial Progenitor Cells Derived Exosomes Boosts Their Beneficial Effects on Hypoxia/Reoxygeneation-Injured Human Endothelial Cells via Protecting Mitochondrial Function.Cell. Physiol. Biochem.201846266467510.1159/000488635 29621777
     [Google Scholar]
  4. ZaccagniniG. GrecoS. VoellenkleC. GaetanoC. MartelliF. miR-210 hypoxamiR in Angiogenesis and Diabetes.Antioxid. Redox Signal.20223610-1268570610.1089/ars.2021.0200 34521246
     [Google Scholar]
  5. ZhouZ. ColladoA. SunC. Downregulation of Erythrocyte miR-210 Induces Endothelial Dysfunction in Type 2 Diabetes.Diabetes202271228529710.2337/db21‑0093 34753800
     [Google Scholar]
  6. ZhangH. WuJ. WuJ. Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice.J. Nanobiotechnology20191712910.1186/s12951‑019‑0461‑7 30782171
     [Google Scholar]
  7. BirkM. BaumE. ZadehJ.K. Angiotensin II Induces Oxidative Stress and Endothelial Dysfunction in Mouse Ophthalmic Arteries via Involvement of AT1 Receptors and NOX2.Antioxidants (Basel) 202110810.3390/antiox10081238 34439486
     [Google Scholar]
  8. MuñozM. López-OlivaM.E. RodríguezC. Differential contribution of Nox1, Nox2 and Nox4 to kidney vascular oxidative stress and endothelial dysfunction in obesity.Redox Biol.20202810133010.1016/j.redox.2019.101330 31563085
     [Google Scholar]
  9. XuX. ZhangH. LiJ. Combination of EPC-EXs and NPC-EXs with miR-126 and miR-210 overexpression produces better therapeutic effects on ischemic stroke by protecting neurons through the Nox2/ROS and BDNF/TrkB pathways.Exp. Neurol.202335911423510.1016/j.expneurol.2022.114235 36174747
     [Google Scholar]
  10. LiuH. WangJ. ChenY. NPC-EXs Alleviate Endothelial Oxidative Stress and Dysfunction through the miR-210 Downstream Nox2 and VEGFR2 Pathways.Oxid. Med. Cell. Longev.20172017939763110.1155/2017/9397631 28630660
     [Google Scholar]
  11. ZhangJ. WuC. GaoL. DuG. QinX. Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects.Adv. Pharmacol.2020878911210.1016/bs.apha.2019.08.002 32089240
     [Google Scholar]
  12. XuC. TangF. LuM. Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways.Int. Immunopharmacol.20163311912710.1016/j.intimp.2016.02.009 26903414
     [Google Scholar]
  13. LengB. TangF. LuM. Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway.Life Sci.201820911112110.1016/j.lfs.2018.07.053 30081006
     [Google Scholar]
  14. ZouX. XiaoH. BaiX. Astragaloside IV drug-loaded exosomes (AS-IV EXOs) derived from endothelial progenitor cells improve the viability and tube formation in high-glucose impaired human endothelial cells by promoting miR-214 expression.Endokrynol. Pol.202273233634510.5603/EP.a2022.0011 35593682
     [Google Scholar]
  15. JosephJ.J. DeedwaniaP. AcharyaT. Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association.Circulation20221459e722e5910.1161/cir.0000000000001040 35000404
     [Google Scholar]
  16. YunJ.S. KoS.H. Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes.Metabolism202112315483810.1016/j.metabol.2021.154838 34333002
     [Google Scholar]
  17. ShaitoA. AramouniK. AssafR. Oxidative Stress-Induced Endothelial Dysfunction in Cardiovascular Diseases.Front. Biosci. (Landmark Ed.)202227310510.31083/j.fbl2703105 35345337
     [Google Scholar]
  18. SenaC.M. PereiraA.M. SeiçaR. Endothelial dysfunction - a major mediator of diabetic vascular disease.Biochim. Biophys. Acta20131832122216223110.1016/j.bbadis.2013.08.006 23994612
     [Google Scholar]
  19. LiT. SongX. ZhangJ. Protection of Human Umbilical Vein Endothelial Cells against Oxidative Stress by MicroRNA-210.Oxidative medicine and cellular longevity 20172017356561310.1155/2017/3565613 28367268
     [Google Scholar]
  20. DiaoH. LiuB. ShiY. MicroRNA-210 alleviates oxidative stress-associated cardiomyocyte apoptosis by regulating BNIP3.Bioscience, biotechnology, and biochemistry20178191712172010.1080/09168451.2017.1343118 28661226
     [Google Scholar]
  21. XuJ. HuangZ. LinL. miR-210 over-expression enhances mesenchymal stem cell survival in an oxidative stress environment through antioxidation and c-Met pathway activation.Sci. China Life Sci.2014571098999710.1007/s11427‑014‑4725‑z 25168379
     [Google Scholar]
  22. XiongW. HuangX.L. LiC.Y. Astragaloside IV - mediated endothelial progenitor cell exosomes promote autophagy and inhibit apoptosis in hyperglycemic damaged endothelial cells via miR-21/PTEN axis.Folia Histochem. Cytobiol.202260432333410.5603/FHC.a2022.0030 36504133
     [Google Scholar]
  23. XiongW. ZhouJ.D. TanM.X. Astragaloside IV (ASIV) Mediates Endothelial Progenitor Cell (EPC) Exosomal LINC01963 to Inhibit Pyroptosis and Oxidative Stress in High Glucose-impaired Endothelial Cells.Curr. Mol. Med.202310.2174/1566524023666230111163718 36631922
     [Google Scholar]
  24. FanL.M. LiuF. DuJ. GengL. LiJ.M. Inhibition of endothelial Nox2 activation by LMH001 protects mice from angiotensin II-induced vascular oxidative stress, hypertension and aortic aneurysm.Redox Biol.20225110226910.1016/j.redox.2022.102269 35276443
     [Google Scholar]
  25. HaddadP. DussaultS. GroleauJ. Nox2-derived reactive oxygen species contribute to hypercholesterolemia-induced inhibition of neovascularization: effects on endothelial progenitor cells and mature endothelial cells.Atherosclerosis2011217234034910.1016/j.atherosclerosis.2011.03.038 21524749
     [Google Scholar]
  26. HuC. WuZ. HuangZ. Nox2 impairs VEGF-A-induced angiogenesis in placenta via mitochondrial ROS-STAT3 pathway.Redox Biol.20214510205110.1016/j.redox.2021.102051 34217063
     [Google Scholar]
/content/journals/cmm/10.2174/0115665240262982240109104620
Loading
Exosomes Derived from Astragaloside IV-pretreated Endothelial Progenitor Cells (AS-IV-Exos) Alleviated Endothelial Oxidative Stress and Dysfunction via the miR-210/ Nox2/ROS Pathway
Current Molecular Medicine 25, 320 (2025); https://doi.org/10.2174/0115665240262982240109104620
/content/journals/cmm/10.2174/0115665240262982240109104620
/content/journals/cmm/10.2174/0115665240262982240109104620
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): astragaloside IV; endothelial dysfunction; exosomes; miR-210; Nox2; oxidative stress

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test